| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.2990230103 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990230103 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.2990230103 | ||
| P698 | PubMed publication ID | 7687782 |
| P2093 | author name string | K. Griffiths | |
| W. B. Peeling | |||
| M. E. Harper | |||
| D. W. Wilson | |||
| L. Goddard | |||
| E. Glynne-Jones | |||
| M. Price-Thomas | |||
| P2860 | cites work | Differential expression of epidermal growth factor-related proteins in human colorectal tumors | Q28610061 |
| Human transforming growth factor-alpha: precursor structure and expression in E. coli | Q34245148 | ||
| Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands | Q34474625 | ||
| Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal | Q35814918 | ||
| Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study. | Q35982524 | ||
| Production of transforming growth factor-alpha in human tumour cell lines | Q36467731 | ||
| Developmental expression of transforming growth factors alpha and beta in mouse fetus | Q36793569 | ||
| Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua | Q36843086 | ||
| Expression of epidermal growth factor receptor in breast carcinoma | Q37257979 | ||
| Autocrine growth factors and cancer | Q39815279 | ||
| Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia | Q42050496 | ||
| Expression of transforming growth factor-alpha in primary human colon and lung carcinomas | Q42087783 | ||
| Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters | Q43549648 | ||
| TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas | Q43826975 | ||
| Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma | Q44012397 | ||
| Clinical significance of oncogenes and growth factors in ovarian carcinomas | Q44147854 | ||
| Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation | Q44545201 | ||
| Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues | Q48502152 | ||
| Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor | Q53553601 | ||
| Suramin: an anticancer drug with a unique mechanism of action. | Q55242277 | ||
| Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu | Q58212590 | ||
| TGF-α Is Widely Expressed in Differentiated as well as Hyperproliferative Skin Epithelium | Q63300954 | ||
| Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast | Q67660860 | ||
| Steroids and the prostate | Q68068828 | ||
| Growth factor involvement and oncogene expression in prostatic tumours | Q68095164 | ||
| Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice | Q68462882 | ||
| In situ distribution of transforming growth factor alpha in normal human tissues and in malignant tumours of the ovary | Q68642134 | ||
| Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells | Q68822985 | ||
| Immunohistochemical localization of epidermal growth factor in rat and man | Q68917023 | ||
| Role of transforming growth factor-alpha in human prostate cancer cell growth | Q69761433 | ||
| Immunohistochemical detection of human epidermal growth factor in submandibular glands and their tumors using a polyclonal antiserum and a monoclonal antibody | Q70370359 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9-23 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors | |
| An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors | |||
| P478 | volume | 23 |
| Q34057806 | Chemotherapy for hormone-refractory prostate cancer: beauty is in the eye of the beholder |
| Q71235333 | Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue |
| Q40781423 | Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways |
| Q60300145 | Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells |
| Q41256344 | Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone |
| Q42479065 | Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumours |
| Q40958225 | Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate |
| Q40647881 | ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. |
| Q33955332 | Growth factors and epithelial-stromal interactions in prostate cancer development |
| Q40958208 | Growth factors as mediators of androgen action during the development of the male urogenital tract |
| Q74366107 | Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen |
| Q42522406 | Immunolocalization of transforming growth factor alpha in normal human tissues. |
| Q35054043 | Immunopathological prognostic and predictive factors in prostate cancer |
| Q43981261 | Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor. |
| Q40641909 | Prostate cancer progression. Implications of histopathology. |
| Q42458424 | The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions |
| Q41718644 | The molecular pathology of urological malignancies |
| Q39999738 | Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells |
Search more.